These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34990063)

  • 1. Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review.
    Moattari CR; França K
    J Dtsch Dermatol Ges; 2022 Jan; 20(1):7-15. PubMed ID: 34990063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulant-induced trichotillomania.
    Hamalian G; Citrome L
    Subst Abus; 2010 Jan; 31(1):68-70. PubMed ID: 20391272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant use in patients presenting with psychocutaneous disorders.
    Richey PM; Laageide L; Swick BL
    J Am Acad Dermatol; 2022 May; 86(5):1002-1009. PubMed ID: 33878406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversion of prescription stimulant drugs among 10-18-year-olds.
    Lasopa SO; Striley CW; Cottler LB
    Curr Opin Psychiatry; 2015 Jul; 28(4):292-8. PubMed ID: 26001920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant prescription cautions: addressing misuse, diversion and malingering.
    Rabiner DL
    Curr Psychiatry Rep; 2013 Jul; 15(7):375. PubMed ID: 23712725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N; Keim S; Adesman A
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Household Diversion of Prescription Stimulants: Medication Misuse by Parents of Children with Attention-Deficit/Hyperactivity Disorder.
    Pham T; Milanaik R; Kaplan A; Papaioannou H; Adesman A
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):741-746. PubMed ID: 28686059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant medication and substance use outcomes: a meta-analysis.
    Humphreys KL; Eng T; Lee SS
    JAMA Psychiatry; 2013 Jul; 70(7):740-9. PubMed ID: 23754458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students.
    Sepúlveda DR; Thomas LM; McCabe SE; Cranford JA; Boyd CJ; Teter CJ
    J Pharm Pract; 2011 Dec; 24(6):551-60. PubMed ID: 22095577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New-onset trichotillomania during treatment with stimulant drugs. About two pediatric clinical cases].
    Fernández Manso B; Villora Morcillo N; Taboas Pereira MA; Elipe Maldonado C
    Arch Argent Pediatr; 2020 Feb; 118(1):e61-e62. PubMed ID: 31984712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Stimulant Nonmedical Use Among Adolescents Evaluated for Substance Use Disorder Treatment (CHAT™).
    Vosburg SK; Faraone SV; Newcorn JH; Rostain AL; Findling RL; Butler SF; Govoni TD; Green JL
    J Atten Disord; 2021 Nov; 25(13):1859-1870. PubMed ID: 32697138
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.
    Cassidy TA; McNaughton EC; Varughese S; Russo L; Zulueta M; Butler SF
    J Atten Disord; 2015 Apr; 19(4):275-83. PubMed ID: 23900405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.